clindamycin phosphate + benzoyl peroxide + tazarotene

Clindamycin phosphate + benzoyl peroxide + tazarotene is a topical combination therapy used primarily for the treatment of moderate to severe acne vulgaris. This regimen combines three active ingredients with complementary mechanisms of action: - Clindamycin phosphate is a lincosamide antibiotic that inhibits bacterial protein synthesis, targeting Cutibacterium acnes (formerly Propionibacterium acnes), a key bacterium involved in acne pathogenesis. - Benzoyl peroxide acts as an oxidizing agent with antibacterial and keratolytic properties, helping to reduce bacterial load and prevent pore blockage. - Tazarotene is a third-generation topical retinoid that modulates gene expression, normalizes keratinocyte differentiation, reduces inflammation, and decreases comedone formation. Clinical studies have shown that this triple combination provides superior efficacy in reducing both inflammatory (papules/pustules) and non-inflammatory (comedones) acne lesions compared to monotherapy or dual combinations[1][2][4][5]. The combination is generally well-tolerated when applied once daily for up to 12 weeks[4][5].

Other names

benzoyl peroxide and clindamycin and tazarotene